BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 14748738)

  • 1. Antioxidants and atherosclerosis.
    Niki E
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):156-9. PubMed ID: 14748738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis.
    Thomas SR; Stocker R
    Free Radic Biol Med; 2000 Jun; 28(12):1795-805. PubMed ID: 10946221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of oxidation of low-density lipoprotein by a novel antioxidant, BO-653, prepared by theoretical design.
    Noguchi N; Okimoto Y; Tsuchiya J; Cynshi O; Kodama T; Niki E
    Arch Biochem Biophys; 1997 Nov; 347(1):141-7. PubMed ID: 9344475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals.
    Noguchi N; Gotoh N; Niki E
    Biochim Biophys Acta; 1994 Jul; 1213(2):176-82. PubMed ID: 8025128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized low-density lipoprotein and atherosclerosis.
    Devaraj S; Jialal I
    Int J Clin Lab Res; 1996; 26(3):178-84. PubMed ID: 8905449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of oxidative modification of low density lipoprotein by antioxidants.
    Niki E; Noguchi N; Gotoh N
    J Nutr Sci Vitaminol (Tokyo); 1993; 39 Suppl():S1-8. PubMed ID: 8164063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of low-density lipoprotein and atherosclerosis in chronic renal failure.
    Hasselwander O; Young IS
    Med Hypotheses; 1997 Nov; 49(5):389-95. PubMed ID: 9421803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation.
    Frei B
    Crit Rev Food Sci Nutr; 1995 Jan; 35(1-2):83-98. PubMed ID: 7748483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of vitamin E in atherosclerosis.
    Upston JM; Kritharides L; Stocker R
    Prog Lipid Res; 2003 Sep; 42(5):405-22. PubMed ID: 12814643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antioxidants against atherosclerosis.
    Niki E; Noguchi N
    Mol Cell Biochem; 2002; 234-235(1-2):19-25. PubMed ID: 12162433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypochlorite induces the formation of LDL(-), a potentially atherogenic low density lipoprotein subspecies.
    Fabjan JS; Abuja PM; Schaur RJ; Sevanian A
    FEBS Lett; 2001 Jun; 499(1-2):69-72. PubMed ID: 11418114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of human low-density lipoprotein oxidation by salvianolic acid-A].
    Liu YL; Liu GT
    Yao Xue Xue Bao; 2002 Feb; 37(2):81-5. PubMed ID: 12579947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of the copper dependent oxidation of low-density lipoprotein.
    Patel RP; Darley-Usmar VM
    Free Radic Res; 1999 Jan; 30(1):1-9. PubMed ID: 10193568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants, lipoprotein oxidation, and arterial function.
    Bruckdorfer KR
    Lipids; 1996 Mar; 31 Suppl():S83-5. PubMed ID: 8729099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
    Burkitt MJ
    Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of oxidative modification and antioxidants in LDL metabolism and atherosclerosis.
    Jessup W; Dean RT; de Whalley CV; Rankin SM; Leake DS
    Adv Exp Med Biol; 1990; 264():139-42. PubMed ID: 2173869
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of oxidation, antioxidants, and atherosclerosis.
    Parthasarathy S; Santanam N
    Curr Opin Lipidol; 1994 Oct; 5(5):371-5. PubMed ID: 7858912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.